Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.72 - $14.77 $531,388 - $1.37 Million
92,900 New
92,900 $775,000
Q1 2024

May 15, 2024

SELL
$1.5 - $3.41 $6,450 - $14,663
-4,300 Reduced 28.1%
11,000 $27,000
Q4 2023

Feb 14, 2024

BUY
$1.82 - $3.16 $27,846 - $48,348
15,300 New
15,300 $36,000
Q2 2023

Aug 23, 2023

BUY
$7.35 - $13.21 $82,320 - $147,952
11,200 New
11,200 $82,000
Q4 2022

Feb 14, 2023

BUY
$11.0 - $21.45 $31,900 - $62,205
2,900 Added 24.37%
14,800 $175,000
Q3 2022

Nov 14, 2022

SELL
$20.09 - $35.8 $16,072 - $28,639
-800 Reduced 6.3%
11,900 $247,000
Q2 2022

Aug 15, 2022

BUY
$27.42 - $43.63 $170,004 - $270,506
6,200 Added 95.38%
12,700 $388,000
Q1 2022

May 16, 2022

SELL
$36.48 - $52.22 $167,808 - $240,212
-4,600 Reduced 41.44%
6,500 $272,000
Q4 2021

Feb 14, 2022

BUY
$33.11 - $55.01 $23,177 - $38,507
700 Added 6.73%
11,100 $501,000
Q3 2021

Nov 12, 2021

SELL
$50.07 - $66.05 $155,217 - $204,755
-3,100 Reduced 22.96%
10,400 $538,000
Q2 2021

Aug 06, 2021

BUY
$56.61 - $80.46 $509,490 - $724,140
9,000 Added 200.0%
13,500 $864,000
Q1 2021

May 14, 2021

SELL
$86.23 - $125.19 $586,364 - $851,292
-6,800 Reduced 60.18%
4,500 $406,000
Q4 2020

Feb 12, 2021

BUY
$79.17 - $111.47 $174,174 - $245,234
2,200 Added 24.18%
11,300 $1.05 Million
Q3 2020

Nov 13, 2020

BUY
$81.91 - $134.94 $745,381 - $1.23 Million
9,100 New
9,100 $949,000
Q2 2019

Aug 20, 2019

SELL
$39.92 - $53.86 $251,496 - $339,318
-6,300 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$48.23 - $66.16 $96,460 - $132,320
2,000 Added 46.51%
6,300 $318,000
Q4 2018

Feb 14, 2019

BUY
$55.63 - $73.24 $239,209 - $314,932
4,300 New
4,300 $252,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $443M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.